Guardant Health director exercises 155 RSUs
Guardant Health director Steve E. Krognes reported an exercise of restricted stock units that delivered 155 shares of common stock on June 30, 2026.
Rhea-AI Filing Summary
Guardant Health director Steve E. Krognes reported an exercise of restricted stock units that delivered 155 shares of common stock on June 30, 2026. These RSUs were from an award granted on August 9, 2022, which vested 25% on June 30, 2023 and the remaining 75% over the following three years.
After this derivative exercise, Krognes directly holds 14,580 shares of Guardant Health common stock. This Form 4 reflects a compensation-related vesting and conversion of equity awards, with no open-market buying or selling reported in this filing.
Positive
- None.
Negative
- None.
Insider Trade Summary
155 shares exercised/converted
Exercise
2 txns
Insider
Krognes Steve E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 155 | $0.00 | $0.00 |
| Exercise | Common Stock | 155 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 14,580 shares (Direct)
Footnotes (2)
- F1. This represents a restricted stock unit award granted on August 9, 2022. 25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter.
- F2. Not applicable for Restricted Stock Units.
Key Figures
RSUs converted: 155 shares
Exercise price: $0.00 per share
Shares held after transaction: 14,580 shares
+1 more
4 metrics
RSUs converted
155 shares
Restricted Stock Units converted to common stock on June 30, 2026
Exercise price
$0.00 per share
Conversion of restricted stock units to common stock
Shares held after transaction
14,580 shares
Director’s direct common stock holdings following the June 30, 2026 conversion
Remaining RSUs from this award
0 units
Restricted stock unit award granted August 9, 2022 now fully vested
Key Terms
Restricted Stock Units, restricted stock unit award, vested
3 terms
Restricted Stock Units financial
"This represents a restricted stock unit award granted on August 9, 2022."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
restricted stock unit award financial
"This represents a restricted stock unit award granted on August 9, 2022."
A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.
vested financial
"25% of the shares subject to such award vested on June 30, 2023 and the remaining 75% of the shares subject to such award vested during the three-year period thereafter."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Guardant Health (GH) report for Steve E. Krognes?
Guardant Health director Steve E. Krognes exercised restricted stock units into 155 shares of common stock. The transaction reflects equity compensation vesting, not an open-market purchase or sale, and was reported on a Form 4 as a derivative exercise/conversion event.
Was the Guardant Health (GH) Form 4 a stock buy or sell by Steve E. Krognes?
The Form 4 does not show a buy or sell; it reports a derivative exercise. Restricted stock units converted into 155 common shares at a zero exercise price, reflecting routine equity compensation vesting rather than an open-market trade by the director.
Does Steve E. Krognes have any remaining restricted stock units after this Guardant Health transaction?
After this transaction, the reported restricted stock unit position shows zero units remaining. The Form 4 indicates 155 RSUs were converted into 155 common shares, completing this particular award’s vesting and leaving no RSUs from that grant outstanding.
AI-generated analysis. How Rhea-AI works. Not financial advice.
